Literature DB >> 32680955

TH17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity.

Stacey N Harbour1, Daniel F DiToro1, Steven J Witte1, Carlene L Zindl1, Min Gao2,3, Trenton R Schoeb2, Gareth W Jones4,5,6, Simon A Jones5,6, Robin D Hatton1, Casey T Weaver7.   

Abstract

Acting in concert with TGF-β, interleukin-6 (IL-6) signaling induces T helper 17 (TH17) cell development by programming TH17-related genes via signal transducers and activators of transcription 3 (STAT3). A role for IL-6 signaling beyond the inductive phase of TH17 cell development has not been defined because IL-23 signaling downstream of TH17 cell induction also activates STAT3 and is thought responsible for TH17 cell maintenance. Here, we find that IL-6 signaling is required for both induction and maintenance of mouse TH17 cells; IL-6Rα-deficient TH17 cells rapidly lost their TH17 phenotype and did not cause disease in two models of colitis. Cotransfer of wild-type TH17 cells with IL-6Rα-deficient TH17 cells induced colitis but was unable to rescue phenotype loss of the latter. High IL-6 expression in the colon promoted classic, or cis, rather than transreceptor signaling that was required for maintenance of TH17 cells. Thus, ongoing classic IL-6 signaling underpins the TH17 program and is required for TH17 cell maintenance and function.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32680955      PMCID: PMC7843024          DOI: 10.1126/sciimmunol.aaw2262

Source DB:  PubMed          Journal:  Sci Immunol        ISSN: 2470-9468


  95 in total

1.  A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.

Authors:  Richard H Duerr; Kent D Taylor; Steven R Brant; John D Rioux; Mark S Silverberg; Mark J Daly; A Hillary Steinhart; Clara Abraham; Miguel Regueiro; Anne Griffiths; Themistocles Dassopoulos; Alain Bitton; Huiying Yang; Stephan Targan; Lisa Wu Datta; Emily O Kistner; L Philip Schumm; Annette T Lee; Peter K Gregersen; M Michael Barmada; Jerome I Rotter; Dan L Nicolae; Judy H Cho
Journal:  Science       Date:  2006-10-26       Impact factor: 47.728

2.  gp130, the cytokine common signal-transducer of interleukin-6 cytokine family, is downregulated in T cells in vivo by interleukin-6.

Authors:  X J Wang; T Taga; K Yoshida; M Saito; T Kishimoto; H Kikutani
Journal:  Blood       Date:  1998-05-01       Impact factor: 22.113

3.  IL-6 rescues resting mouse T cells from apoptosis.

Authors:  T K Teague; P Marrack; J W Kappler; A T Vella
Journal:  J Immunol       Date:  1997-06-15       Impact factor: 5.422

Review 4.  Reciprocal interactions of the intestinal microbiota and immune system.

Authors:  Craig L Maynard; Charles O Elson; Robin D Hatton; Casey T Weaver
Journal:  Nature       Date:  2012-09-13       Impact factor: 49.962

Review 5.  Interleukin 6 and its receptor: ten years later.

Authors:  T Hirano
Journal:  Int Rev Immunol       Date:  1998       Impact factor: 5.311

6.  A protective function for interleukin 17A in T cell-mediated intestinal inflammation.

Authors:  William O'Connor; Masahito Kamanaka; Carmen J Booth; Terrence Town; Susumu Nakae; Yoichiro Iwakura; Jay K Kolls; Richard A Flavell
Journal:  Nat Immunol       Date:  2009-06       Impact factor: 25.606

7.  The Molecular Signatures Database (MSigDB) hallmark gene set collection.

Authors:  Arthur Liberzon; Chet Birger; Helga Thorvaldsdóttir; Mahmoud Ghandi; Jill P Mesirov; Pablo Tamayo
Journal:  Cell Syst       Date:  2015-12-23       Impact factor: 10.304

8.  Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat.

Authors:  Kenji Ichiyama; Hideyuki Yoshida; Yu Wakabayashi; Takatoshi Chinen; Kazuko Saeki; Mako Nakaya; Giichi Takaesu; Shohei Hori; Akihiko Yoshimura; Takashi Kobayashi
Journal:  J Biol Chem       Date:  2008-04-23       Impact factor: 5.157

9.  Interleukin-23 drives innate and T cell-mediated intestinal inflammation.

Authors:  Sophie Hue; Philip Ahern; Sofia Buonocore; Marika C Kullberg; Daniel J Cua; Brent S McKenzie; Fiona Powrie; Kevin J Maloy
Journal:  J Exp Med       Date:  2006-10-09       Impact factor: 14.307

10.  Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.

Authors:  F Powrie; R Correa-Oliveira; S Mauze; R L Coffman
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

View more
  18 in total

1.  β-Adrenoceptor Blockade Moderates Neuroinflammation in Male and Female EAE Rats and Abrogates Sexual Dimorphisms in the Major Neuroinflammatory Pathways by Being More Efficient in Males.

Authors:  Ivan Pilipović; Zorica Stojić-Vukanić; Ivana Prijić; Nebojša Jasnić; Jelena Djordjević; Gordana Leposavić
Journal:  Cell Mol Neurobiol       Date:  2022-07-08       Impact factor: 5.046

2.  IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis.

Authors:  Marko Petržalka; Eva Meluzínová; Jana Libertínová; Hana Mojžišová; Jitka Hanzalová; Petra Ročková; Martin Elišák; Silvia Kmetonyová; Jan Šanda; Ondřej Sobek; Petr Marusič
Journal:  PLoS One       Date:  2022-06-27       Impact factor: 3.752

Review 3.  The Conundrum of Lung Disease and Drug Hypersensitivity-like Reactions in Systemic Juvenile Idiopathic Arthritis.

Authors:  Bryce A Binstadt; Peter A Nigrovic
Journal:  Arthritis Rheumatol       Date:  2022-05-29       Impact factor: 15.483

4.  Exaggerated IL-17A activity in human in vivo recall responses discriminates active tuberculosis from latent infection and cured disease.

Authors:  Gabriele Pollara; Carolin T Turner; Joshua Rosenheim; Aneesh Chandran; Lucy C K Bell; Ayesha Khan; Amit Patel; Luis Felipe Peralta; Anna Folino; Ayse Akarca; Cristina Venturini; Tina Baker; Simone Ecker; Fabio L M Ricciardolo; Teresa Marafioti; Cesar Ugarte-Gil; David A J Moore; Benjamin M Chain; Gillian S Tomlinson; Mahdad Noursadeghi
Journal:  Sci Transl Med       Date:  2021-05-05       Impact factor: 17.956

5.  Use of immune checkpoint inhibitors in cancer patients with pre-existing sarcoidosis.

Authors:  Sang T Kim; Xerxes Pundole; Ramona Dadu; Olivier Lambotte; Manuel Ramos-Casals; Maria E Suarez-Almazor
Journal:  Immunotherapy       Date:  2021-03-01       Impact factor: 4.196

6.  Maternal gut bacteria drive intestinal inflammation in offspring with neurodevelopmental disorders by altering the chromatin landscape of CD4+ T cells.

Authors:  Eunha Kim; Donggi Paik; Ricardo N Ramirez; Delaney G Biggs; Youngjun Park; Ho-Keun Kwon; Gloria B Choi; Jun R Huh
Journal:  Immunity       Date:  2021-12-07       Impact factor: 31.745

7.  Inflammatory Pathways in Sarcoidosis.

Authors:  Barbara P Barna; Marc A Judson; Mary Jane Thomassen
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

8.  Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary Complications.

Authors:  Sang T Kim; Ajay Sheshadri; Vickie Shannon; Dimitrios P Kontoyiannis; Hagop Kantarjian; Guillermo Garcia-Manero; Farhad Ravandi; Jin S Im; Prajwal Boddu; Lara Bashoura; Diwakar D Balachandran; Scott E Evans; Saadia Faiz; Wilfredo Ruiz Vazquez; Margarita Divenko; Rohit Mathur; Samantha P Tippen; Curtis Gumbs; Sattva S Neelapu; Aung Naing; Linghua Wang; Adi Diab; Andrew Futreal; Roza Nurieva; Naval Daver
Journal:  Front Immunol       Date:  2021-01-21       Impact factor: 7.561

9.  STAT5 Represses a STAT3-Independent Th17-like Program during Th9 Cell Differentiation.

Authors:  D Alejandro Canaria; Bingyu Yan; Maia G Clare; Zonghao Zhang; Grace A Taylor; David L Boone; Majid Kazemian; Matthew R Olson
Journal:  J Immunol       Date:  2021-08-04       Impact factor: 5.426

10.  Newly developed pseudogout arthritis after therapy with MAGE-A4 directed TCR T cells responded to treatment with tocilizumab.

Authors:  Sang T Kim; Jean Tayar; Siqing Fu; Danxia Ke; Elliot Norry; Amy Sun; Juli Miller; David S Hong
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.